The miracle drugs helping America fight obesity can have a dangerous downside: triggering disordered eating.

CAD $3.5 million, three-year project will support development of brain-targeted small molecules designed to address the biology of habit and compulsion MONTRÉAL, June 30, 2026 /PRNewswire/ --Will ...

A study found that the use of Epidiolox, an FDA-approved, plant-derived formulation of cannabidinol (CBD), promotes weight gain in patients with anorexia nervosa. Anorexia nervosa is a severe ...

Relapses are among the biggest challenges in anorexia, even after successful treatment. Why is that? French researchers have now discovered a mechanism that not only helps to better understand ...

Will Therapeutics, an early-stage biotechnology company developing novel small-molecule medicines for psychiatric and compulsive disorders, today announced that its collaborative research project with ...